Actively Recruiting
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
Led by Yunnan Cancer Hospital · Updated on 2024-07-11
400
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the value of rapid on-site evaluation（ROSE） in lymph node biopsy of breast cancer. The main question it aims to answer is:The ROSE technique was applied to breast cancer lymph node biopsy to improve the diagnostic efficiency and accuracy. Participants underwent routine lymph node biopsy, and the test personnel conducted routine disease examination and rose technique evaluation on the removed ly
CONDITIONS
Official Title
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients had pathologically confirmed primary breast cancer
- Surgical treatment was available
You will not qualify if you...
- Previous history of surgery on the affected axilla, internal breast or chest
- Pregnant or breastfeeding patients
- Previous radiotherapy or chemotherapy
- Complicated history of other tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunnan Cancer Hospital
Kunming, Yunnan, China
Actively Recruiting
Research Team
Q
Qi Tang, Doctor's degree
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here